Post-infection cough
Conditions
Interventions
Intervention Group:Health promotion+Sangting Formula
Control Group:Health promotion+Sangting Formula Placebo
Sponsors
Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for post-infection cough as per the "Guidelines for the Diagnosis and Treatment of Cough (2021)"; (2) Meets the diagnostic criteria for lung-spleen damp-heat syndrome; (3) Age between 18 and 65 years; (4) Disease duration =3 weeks and 5 points; (6) VAS score =40 mm; (7) Voluntarily participates and signs the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with severe cardiovascular and cerebrovascular diseases, hepatic and renal insufficiency, hematological disorders, or mental illness; (2) Patients with cough or other pulmonary diseases caused by chronic bronchitis, eosinophilic bronchitis, cough-variant asthma, gastroesophageal reflux disease (GERD), etc.; (3) Patients with a temperature >37.3°C and acute infection; (4) Patients who have taken ACEI (ACEI antihypertensive drugs) within the past 3 months; (5) Heavy smokers (smoking history (years) multiplied by the number of cigarettes smoked per day =400); (6) Pregnant or breastfeeding women; (7) Patients with a known allergy to the investigational drug; (8) Patients currently participating in other interventional clinical trials; (9) Other situations deemed unsuitable for participation in this study by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough resolution rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cough onset time;The efficacy of cough;Cough Cessation Time;Traditional Chinese Medicine (TCM) Syndrome Efficacy;Leicester Cough Quality of Life Questionnaire Score Changes;Cough severity rating change; | — |
Countries
China
Contacts
Public ContactXiaohong Gu
Beijing University of Chinese Medicine
Outcome results
None listed